HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Carlos A Molina Selected Research

Tissue Plasminogen Activator (Alteplase)

12/2015Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data.
10/2015Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
6/2015Thrombectomy within 8 hours after symptom onset in ischemic stroke.
6/2015REVASCAT: a randomized trial of revascularization with SOLITAIRE FR device vs. best medical therapy in the treatment of acute stroke due to anterior circulation large vessel occlusion presenting within eight-hours of symptom onset.
5/2015Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial.
9/2014Impact of time to treatment on tissue-type plasminogen activator-induced recanalization in acute ischemic stroke.
4/2014Baseline National Institutes of Health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke.
2/2014Fluorescent molecular peroxidation products: a prognostic biomarker of early neurologic deterioration after thrombolysis.
3/2013Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.
5/2012Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Carlos A Molina Research Topics

Disease

71Stroke (Strokes)
12/2015 - 06/2002
7Cerebral Hemorrhage
05/2013 - 07/2003
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2015 - 07/2005
5Intracranial Hemorrhages (Intracranial Hemorrhage)
06/2015 - 09/2004
4Thrombosis (Thrombus)
10/2015 - 01/2007
3Neoplasms (Cancer)
09/2013 - 11/2002
3Myocardial Infarction
02/2012 - 06/2008
3Ischemia
12/2011 - 02/2003
3Transient Ischemic Attack
09/2011 - 10/2003
3Hemorrhage
01/2011 - 03/2009
3Diabetes Mellitus
01/2011 - 05/2003
3Inflammation
12/2010 - 07/2007
3Brain Injuries (Brain Injury)
12/2010 - 07/2005
3Hyperglycemia
09/2007 - 05/2003
3Brain Ischemia (Cerebral Ischemia)
03/2007 - 12/2003
2Atrial Fibrillation
08/2014 - 08/2008
2Hypertension (High Blood Pressure)
02/2014 - 01/2007
2Hematoma
09/2011 - 03/2009
2Pathologic Constriction (Stenosis)
09/2011 - 01/2005
1Cerebral Infarction
01/2013
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2012
1Coronary Artery Disease (Coronary Atherosclerosis)
09/2011
1Cardiovascular Diseases (Cardiovascular Disease)
09/2011
1Overweight
06/2011
1Infarction
08/2008
1Ventricular Dysfunction
06/2008
1Neoplasm Metastasis (Metastasis)
03/2008
1Atherosclerosis
12/2007
1Endotoxemia
07/2007
1Carotid Stenosis (Carotid Artery Stenosis)
11/2006
1Heart Failure
05/2005
1Intracranial Arteriosclerosis (Cerebral Atherosclerosis)
01/2005
1Spinal Cord Injuries (Spinal Cord Injury)
01/2004
1Hypertrophy
07/2003

Drug/Important Bio-Agent (IBA)

39Tissue Plasminogen Activator (Alteplase)FDA Link
12/2015 - 06/2002
10glucuronyl glucosamine glycan sulfate (Vessel)IBA
11/2015 - 02/2004
5Glucose (Dextrose)FDA LinkGeneric
01/2011 - 05/2003
5Matrix MetalloproteinasesIBA
05/2008 - 12/2003
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2006 - 02/2003
3Biological Markers (Surrogate Marker)IBA
08/2014 - 08/2008
3UbiquitinIBA
09/2013 - 06/2008
3C-Reactive ProteinIBA
05/2008 - 10/2003
2cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2012 - 12/2011
2ThrombinFDA Link
10/2009 - 04/2003
2danaproid (danaparoid)FDA Link
12/2007 - 02/2004
2Carboxypeptidase U (TAFI)IBA
09/2004 - 04/2003
2Plasminogen Activator Inhibitor 1IBA
09/2004 - 06/2004
1Vitamin KFDA Link
11/2015
1Warfarin (Coumadin)FDA LinkGeneric
11/2015
14-(fluoromethyl)phenyl phosphate (FMPP)IBA
02/2014
1Protein Kinases (Protein Kinase)IBA
09/2013
1RNA (Ribonucleic Acid)IBA
05/2012
1Amyloid (Amyloid Fibrils)IBA
01/2012
1LDL CholesterolIBA
09/2011
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
09/2011
15'-palmitoyl cytarabine (PLAC)IBA
09/2011
1ChemokinesIBA
12/2010
1boldenone undecylenate (Equipoise)IBA
12/2010
1CytokinesIBA
12/2010
1human AOC3 proteinIBA
07/2010
1Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2010
1antineoplaston A10 (A 10)IBA
05/2010
1antithrombin III-protease complexIBA
10/2009
14- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
07/2009
1tyramine-deoxysorbitolIBA
03/2009
1fibrin fragment D (D-dimer)IBA
08/2008
1Advanced Glycosylation End ProductsIBA
08/2008
1Fas Ligand Protein (Fas Ligand)IBA
06/2008
1CD95 Antigens (fas Receptor)IBA
06/2008
1Lipoprotein(a)IBA
05/2008
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2008
1Plasminogen Activators (Plasminogen Activator)IBA
05/2008
1E-SelectinIBA
05/2008
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2008
1PeptidesIBA
03/2008
1TachykininsIBA
03/2008
1Chemokine CXCL12IBA
03/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2007
1Calcitonin Gene-Related PeptideIBA
07/2007
1NeuropeptidesIBA
07/2007
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
06/2006
1Isoproterenol (Isoprenaline)FDA LinkGeneric
05/2005
1Phosphodiesterase 3 InhibitorsIBA
05/2005
1EndostatinsIBA
01/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2005
1Cyclic AMP (AMP, Cyclic)IBA
01/2004
1Testosterone (Sustanon)FDA Link
01/2004
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
07/2003
1Carrier Proteins (Binding Protein)IBA
07/2003
1Adrenergic Receptors (Adrenergic Receptor)IBA
07/2003

Therapy/Procedure

5Endovascular Procedures
10/2015 - 01/2013
5Thrombolytic Therapy
06/2010 - 07/2005
2Stents
06/2015 - 11/2006
2Thrombectomy
06/2015 - 01/2014
2Aftercare (After-Treatment)
05/2013 - 04/2011
2Microbubbles
10/2008 - 02/2006
1Embolectomy
06/2015
1Length of Stay
05/2015
1Catheters
05/2013
1Microspheres (Microsphere)
02/2010